Posted Jul. 27, 2010 at 2:33 p.m.

PPD, Microsoft to partner on new solution for FDA risk programs

Print this blog post

Local Tech Wire

WILMINGTON, N.C. – Pharmaceutical Product Development (Nasdaq: PPDI) and Microsoft (Nasdaq: MSFT) are launching a joint effort to design a solutions platform for risk management and other FDA-mandated programs.

The companies said they want to develop a program that helps biotech and pharmaceutical firms comply with FDA Risk Evaluation and Mitigation Strategy, or REMS, programs.

Financial terms were not disclosed.

PPD, a provider of services to life science firms around the globe, will provide scientific, operational, regulatory and strategic support to the project.

The solution will utilize Microsoft’s Amalga Unified Intelligence System, a program for data aggregation, as well as Microsoft HealthVault, which is geared to individual consumers for storage and sharing of health information.

“Efficient, effective REMS programs require real-time access to information by multiple internal and external stakeholders,” said Mike Wilkinson, PPD’s executive vice president and chief information officer, in a statement. “We are committed to combining operational and scientific excellence with leading REMS-specific technologies for this rapidly evolving sector of our industry and are pleased to collaborate with Microsoft in this effort.”

Get the latest news alerts: Follow LTW at Twitter.
 

Copyright 2012 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Featured